NCT05110248 Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application
| NCT ID | NCT05110248 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Perspectum |
| Condition | Multiple |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2021-11-15 |
| Primary Completion | 2031-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2021-11-15 with a primary completion date of 2031-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cross-sectional observational study to improve MRI data acquisition techniques by optimising MRI sequences for multiple organs and assessing the repeatability and reproducibility of multiparametric MRI, in healthy volunteers.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years and older * Participant is willing and able to give informed consent for participation in the study * The participant has a level of English proficiency that allows them to communicate well with the investigator and could comply with study requirements. * The participant is willing and able to undergo MRI scan. Exclusion Criteria: * Any contraindication to magnetic resonance imaging (incl. pregnancy, nonremovable electronic implants including cochlear implants, infusion pumps, and pacemakers, shrapnel injury, severe claustrophobia, allergic reaction to contrast agents) * Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the participant's ability to participate in the study * The participant may be excluded where body habitus is likely to make MRI or echocardiography/ultrasound uncomfortable or unlikely to yield analysable images, and BMI more than 40-45
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05110248 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05110248 currently recruiting?
Yes, NCT05110248 is actively recruiting participants. Contact the research team at soubera.rymell@perspectum.com for enrollment information.
Where is the NCT05110248 trial being conducted?
This trial is being conducted at Oxford, United Kingdom.
Who is sponsoring the NCT05110248 clinical trial?
NCT05110248 is sponsored by Perspectum. The trial plans to enroll 600 participants.